
About Tongshu Biotechnology
Tongshu Biotechnology is a Healthcare company based in Shanghai (China) founded in 2016. Research lab focused on gene sequencing technology and biological information analysis. Tongshu Biotechnology has raised $92.27 million across 4 funding rounds from investors including Broad Vision Funds, GL Capital and Langmafeng Venture Capital. Its chief executive, as recorded, is Yan Linghua. Its focus areas include Medical Research Labs.
Company details
Tongshu Biotechnology research lab focused on gene sequencing technology and biological information analysis, focusing on providing healthcare solutions, and medical research labs. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Shanghai, China
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website tongshugene.net
- Total Equity Funding$92.27M (USD)
in 4 rounds
- Latest Funding Round$14.15M (USD), Series D
Oct 2024
- InvestorsBroad Vision Funds
& 7 more
Funding Insights of Tongshu Biotechnology
Tongshu Biotechnology has successfully raised a total of $92.27M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $14.15 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $92.27M
- Total Rounds 4
- Last Round Series D β $14.15M
- Investors Count 8
All 4 funding rounds of Tongshu Biotechnology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2024 | $14.15M | Series D | β | β | |
| Jun 2021 | $78.12M | Series C | β | Gl-investment, Broad Vision Funds | |
| Sep 2020 | Series B | β | Langmafeng Venture Capital, Yuanbio Venture Capital | ||
| Jun 2018 | Series A | β | β |
8 investors in total: 8 institutional.
Investors in Tongshu Biotechnology
Tongshu Biotechnology has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Broad Vision Funds, GL Capital and Langmafeng Venture Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Consumer technology, healthcare, and sectors are targeted for venture investments. | broadvisionfunds.com | Beijing, China | ||
Venture capital investments are provided to high-tech enterprises. | lmfvc.com | Shenzhen, China | ||
BioVenture is focused on early and growth-stage healthcare investments. | 2013 | bioventure.com.cn | Suzhou, China | |
GL Capital is focused on healthcare sector value investments. | gl-investment.com | Beijing, China | ||
| xmjyjt.com | ||||
Operates as an investment management firm specializing in financial assets. | 2018 | oceanpine.com | Beijing, China | |
Provides comprehensive water management services to support environmental sustainability and efficiency. | 2017 | bangtec.com | Shanghai, China | |
Offers comprehensive health insurance solutions to provide reliable coverage and support for individuals and families. | 2018 | fosunhealthgroup.com | Shanghai, China |
Investor details for Tongshu Biotechnology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Tongshu Biotechnology
1 people are tracked at Tongshu Biotechnology (1 in leadership).
| Name | Role | Group |
|---|---|---|
Yan Linghua | CEO | Leadership |
Complete people profiles for Tongshu Biotechnology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Tongshu Biotechnology
3 dated milestones of Tongshu Biotechnology across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Tongshu Biotechnology is founded.
- Funding First funding round.
- Funding Latest funding round, Series D, of $14.1M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Tongshu Biotechnology
Tongshu Biotechnology was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Tongshu Biotechnology is headquartered in Shanghai, China.
Yan Linghua is the CEO of Tongshu Biotechnology, as recorded in our data.
Tongshu Biotechnology is a funded company, having raised a total of $92.27M across 4 funding rounds to date.
Tongshu Biotechnology research lab focused on gene sequencing technology and biological information analysis, focusing on providing healthcare solutions, and medical research labs. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
Tongshu Biotechnology has 8 investors. Key investors include Broad Vision Funds, GL Capital, Langmafeng Venture Capital, Xiamen Financial Investment Group, and Oceanpine Capital.